Prevalence and related factors of depressive symptoms in hemodialysis patients in northern China by Xiaodan Liu et al.
Liu et al. BMC Psychiatry  (2017) 17:128 
DOI 10.1186/s12888-017-1294-2RESEARCH ARTICLE Open AccessPrevalence and related factors of
depressive symptoms in hemodialysis
patients in northern China
Xiaodan Liu1, Xiaoshi Yang2, Li Yao1, Quan Zhang3, Da Sun1, Xinwang Zhu1, Tianhua Xu1, Qiang Liu1
and Lining Wang1*Abstract
Background: To determine the prevalence of depressive symptoms and to explore related factors of depressive
symptoms in hemodialysis (HD) patients in northern China.
Methods: We used a cross-sectional research design to recruit 227 chronic kidney disease (CKD) patients who were
undergoing HD treatment in northern China during December, 2012 to March, 2013. The Chinese edition of the
Center for Epidemiologic Studies Depression (CES-D) was used to measure depressive symptoms. Information on
quality of life (QOL), activities of daily living (ADL), social support status, coping style, self-efficacy, ego resiliency and
demographic characteristics was all collected by face to face interview. Multivariate logistic regression analysis was
used to explore related factors of depressive symptoms.
Results: The prevalence of depressive symptoms among HD patients was 29.1%. Patients with a lower mood have
worse ADL and QOL than patients with better mood. Patients with a lower mood have got less social support than
patients with better mood, including both family support and outside family support. For coping style, patients
with a lower mood were more inclined to choose “acceptance-resignation” coping style than patients with better
mood, while the result is opposite in “avoidance” coping style. And patients with a better mood have better self-
efficacy and ego resiliency than patients with lower mood. Multivariate logistic regression analyses revealed that
ADL (OR = 1.124, p = 0.002), family support (OR = 0.867, p = 0.021), “acceptance-resignation” coping style (OR = 1.228,
p = 0.022), and ego resiliency (OR = 0.944, p = 0.021) were associated with low mood independently.
Conclusions: The prevalence of depressive symptoms is high in CKD patients on HD in northern China. activities of
daily living, family support, “acceptance-resignation” coping style and ego resiliency were independently associated
with depressive symptoms.
Keywords: Depressive symptoms, Hemodialysis patients, Activities of daily living, Social support, Coping style, Ego
resiliencyBackground
With the prevalence of chronic kidney disease (CKD) at
10.8%, there are up to 119.5 million patients with CKD
in China. A large portion of patients with CKD progress
to end-stage renal disease (ESRD), which need renal re-
placement therapy [1, 2]. At the end of 2013, the* Correspondence: wanglining5623@gmail.com
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mainland China, which puts a huge burden on patients
and the society [3–5].
Depression is a chronic and recurrent illness. Patients
with CKD on hemodialysis (HD) have to endure physical
discomforts related to their illness and have to face vari-
ous stresses, family problems, which increasing the risk
of depression [6]. The prevalence of depression is higher
among patients receiving HD, with estimated rates ran-
ging from 23 to 42% in the USA and Europe, and 45.9%
in Taiwan [7–11]. Furthermore, clinical depression andle is distributed under the terms of the Creative Commons Attribution 4.0
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ated with poor adherence to treatment, increased mor-
tality and rates of hospitalization [12–16].
Although an association between depression and HD
has been strongly suggested, the prevalence and related
factors of depressive symptoms among CKD patients on
HD in northern China are largely unknown. The main
purposes of this study were to (1) assess the prevalence
of depressive symptoms of HD patients in northern
China, (2) explore demographic and clinical characteris-
tics that might identify patients at high risk for depres-
sive symptoms, (3) make comprehensive assessment by
applying questionnaires of quality of life (QOL), social
support, coping style, self-efficacy and ego resiliency,
and try to find correlates of depressive symptoms of pa-
tients on HD.Methods
A cross-sectional study was conducted by cluster sampling
in two affiliated hospitals of China Medical University,
from Dec 12, 2012 to Mar 15, 2013. Patients with CKD
who received HD for at least one month participated in
this study, and were face to face interviewed. Patients were
interviewed while receiving dialysis treatments by medical
students who were extensively and repeatedly trained by
psychiatry faculty. All of the participants were well in-
formed and had written informed consent. The study was
approved by the Ethics Committee on Human Experimen-
tation of The First Hospital of China Medical University.
The inclusion criteria for study participation were as
follows: (1) age > 16 years; (2) ESRD patients who were
undergoing HD therapy for at least one month; (3) had
no history of transplant. The exclusion criteria were (1)
younger than 16 years old; (2) patients with dementia or
cognitive impairment which were defined by self or fam-
ily report; (3) patients with unconsciousness or inability
to read or write; (4) patients with severe complications
of the heart, lung, brain and other parts of the body; (5)
previous treatment for depression. There was no signifi-
cant difference in age, sex and disease between excluded
patients with depression and selected patients.Demographic and clinical characteristics
Demographic characteristics included age, gender, mari-
tal status (married/others), educational level (≤junior
high school/> junior high school), financial status, HD
duration and patient’s functional status.
Data related to clinical characteristics, including cause
of CKD, duration of renal disease, and ionic concentra-
tion were collected from hospital records. In addition,
concern about arteriovenous fistula was also collected
from patient interviews.Questionnaires
Measurement of depressive symptoms
Chinese edition of the Center for Epidemiologic Studies
Depression (CES-D) was used to measure depressive
symptoms [17]. It includes 20 items, with each one com-
prising four categories: (0) never, (1) sometimes, (2) fre-
quently and (3) always. Scores of 16 or more are defined
as depressive symptomes. Participants were divided into
groups of low and normal mood by score of 16. It has
been widely used in Chinese sample with satisfied valid-
ity and reliability (Cronbach’s alpha was 0.8895).Measurement of functional status
Activities of Daily Living Scale (ADL) was used to meas-
ure patient’s functional status [18]. ADL, a 14-item self-
rating scale can be categorized into basic ADL and
instrumental ADL, which evaluated by six items (i.e.
bathing, dressing, walking, toileting, tooth brushing and
eating) and eight items (i.e. meal preparation, shopping,
clothes washing, telephone using, finances managing,
transferring, doing housework, and medicine taking) re-
spectively [19]. Each item is scored on a 4-point scale,
and higher score indicates a higher level of dependence.
(Cronbach’s alpha was 0.8709).Assessment of quality of life
QOL was evaluated by using the 36-item Short-Form
Health Survey (SF-36). The SF-36 measures eight differ-
ent dimensions of health, which is described by a range
from 0 to 100 in score, with a higher score indicating a
better QOL. The accuracy of SF-36 using within Chinese
HD patients has been confirmed previously (Cronbach’s
alpha was 0.9116) [20].Assessment of social support
Perceived Social Support Scale (PSSS) was used to assess
social support status. PSSS, containing 12 self-evaluating
clauses, can be categorized into family support and out-
side family support. Each clause is scored from 1 (strongly
disagree) to 7 (strongly agree), and higher score indicates
a higher social support got by the participant. The reliabil-
ity and validity of the Chinese Version of PSSS are satisfac-
tory (Cronbach’s alpha was 0.8792) [21, 22].Assessment of coping style
Coping style was assessed by using the Chinese edition
of Medical Coping Modes Questionnaire (MCMQ) [23].
It consists of 20 items, including three critical subscales:
confrontation, avoidance, and acceptance-resignation.
(Cronbach’s alpha was 0.7268, 0.6345, and 0.6486,
respectively).
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Self-efficacy was assessed by using the adapted General
Self-efficacy Scale, which was evolved from the English
version. It includes 10 items, and each item is scored on
a 4-point scale, ranging from strong disagreement (1) to
strong agreement (4), and higher score indicates a higher
level of self-efficacy. The reliability of the scale is high
(Cronbach’s alpha was 0.9174).
Assessment of ego resiliency
Ego Resiliency Scale was used to assess ego resiliency
[24]. It includes 14 items rated on a 4-point scale, ran-
ging from low level (1) to high level (4), and higher score
indicates a higher level of ego resiliency [25, 26].
(Cronbach’s alpha was 0.7868).
Statistical analysis
Continuous data are presented as means ± standard de-
viations. Student’s t-test was used to compare the means
of normally distributed variables between “low mood”
and “normal mood”, and the Mann–Whitney U test was
used for variables that were not normally distributed.
Differences among categorical variables were analyzed
by using chi-square test or two-tailed Fisher’s exact test.
Factors associated with depressive symptoms were deter-
mined by multivariate logistic regression analysis. The
variables selected into the multivariable logistic model
were the ones which were statistically significant, or had
significant impacts on the result according to literature
reports.
The Statistical Package for Social Sciences Version
11.5 (SPSS Inc., Chicago, IL, USA) was applied for statis-
tical analysis, and the statistical significance was set at
P < 0.05 (two- tailed test).
Results
Description of demographic and clinical characteristics of
patients
Of the 280 patients asked to participate in this study, 40
declined to participate with an 85.7% consent rate, and
13 were excluded for unqualified questionnaire with
missing values exceeding 10%. Finally, our study sample
was comprised of 227 patients (female, 46.7%; mean age,
49.3 ± 14.3 years, ranging from 17 to 85 years; duration
of HD, mean 40 months, ranging from 1 to 103 months).
Table 1 shows detailed data.
Other causes of ESRD not specified in Table 1 in-
cluded chronic interstitial nephritis (8.8%), polycystic
kidney disease (4.8%), renal allograft loss (3.5%), lupus
nephritis (2.2%), purpura nephritis (1.8%), HBV associ-
ated glomerulonephritis (1.8%), gouty nephropathy
(1.3%), systemic vasculitis (0.9%), obstructive nephropa-
thy (0.4%), trauma (0.4%), and unknown causes (4.9 %).Description of the patients’ depressive symptoms
In our study, sixty-six patients (29.1%) suffered from de-
pressive symptoms. Table 1 shows the demographic
characteristics of all participants. There was no signifi-
cant difference between groups of low and normal mood
in HD duration, marital status, educational level, reli-
gion, primary kidney disease or renal disease duration.
Patients with depressive symptoms had lower monthly
income and concerned more about arteriovenous fistula.
Table 1 also shows the scores of ADL, QOL, social
support, coping style, self-efficacy and ego resiliency. Pa-
tients with a lower mood have worse ADL and QOL
than patients with better mood. For both family support
and outside family support, patients with a lower mood
have got less social support than patients with better
mood. Patients with a lower mood more inclined to
choose “acceptance-resignation” coping style than pa-
tients with better mood, while the result is opposite in
“avoidance” coping style. And patients with a better
mood have better self-efficacy and ego resiliency than
patients with lower mood.
Multivariate logistic regression analysis for related factors
Multivariate logistic regression analyses revealed that
ADL (OR = 1.124, p = 0.002), family support (OR = 0.867,
p = 0.021), “acceptance-resignation” coping style
(OR = 1.228, p = 0.022), and ego resiliency (OR = 0.944,
p = 0.021) were independently associated with low mood
(Table 2).
Discussion
In our study, the prevalence of depressive symptoms in
CKD patients on HD was 29.1%. The result is consistent
with previous data showing a prevalence of depression
in patients on HD ranges from 23% to 45.9% [7, 8].
However, the result is a little higher than the prevalence
of depression among pre-dialysis CKD patients [27, 28].
Compared with the population in developed countries,
Chinese often feel embarrassed to seek mental health
care because of the cultural issues, so that the mental
health status of Chinese has been ignored for decades,
and there are less studies focus on mental health of pa-
tients on HD [29, 30]. Therefore, summarizing the
prevalence of depressive symptoms in patients on HD in
northern China is an important first step, then develop-
ing additional research priorities [31].
Patients with a lower mood have worse ADL than pa-
tients with better mood. Also, ADL was associated with
low mood independently. Our finding was in agreement
with some previous studies [32]. Patients in ESRD strug-
gled to carry out normal daily life despite the depend-
ency caused by the illness [33]. The reality that they
could not finish routine activities independently, such as
bathing or doing housework may be associated with










Gender, n (%) 0.058
Male 121(53.3%) 85(52.8%) 36(54.6%)
Female 106(46.7%) 76(47.2%) 30(45.4%)
Age (years)(mean ± SD)a 49.13 ± 14.20 49.65 ± 14.60 0.804
HD duration (months) 0.351
≤ 24 71(31.2%) 54(33.5%) 17(25.8%)
25–60 78(34.4%) 56(34.8%) 22(33.3%)
>60 78(34.4%) 51(31.7%) 27(40.9%)
Marital status, n (%) 0.820
Married 181(79.7%) 129(80.1%) 52(78.8%)
others 46(20.3%) 32(19.9%) 14(21.2%)
Educational level 0.922
≤ Junior high school 94(41.4%) 67(41.6%) 27(40.9%)
>Junior high school 133(58.6%) 94(58.4%) 39(59.1%)
Monthly income per person (Yuan) 0.008**
<800 42(18.5%) 25(15.5%) 17(25.8%)
800–1499 49(21.6%) 28(17.4%) 21(31.8%)
1500–2999 75(33.0%) 58(36.0%) 17(25.8%)
3000–4999 39(17.2%) 34(21.1%) 5(7.6%)
≥ 5000 22(9.7%) 16(9.9%) 6(9.1%)
Primary kidney disease 0.445
Chronic glomerulonephritis 116(51.1%) 87(54.0%) 29(43.9%)
Diabetic nephropathy 19(8.4%) 13(8.1%) 6(9.1%)
Hypertension 22(9.7%) 13(8.1%) 9(13.6%)
Others 70(30.8%) 48(29.8%) 22(33.3%)
Ca (mmol/L)(mean ± SD)a 2.11 ± 0.30 2.18 ± 0.28 0.074
P (mmol/L)(median(IQR))b,c 2.08(1.05) 1.95(1.30) 0.768
PTH (pmol/L)(median(IQR))b,c 36.67(122.05) 29.12(36.06) 0.300
Total weekly urea Kt/V (mean ± SD)a 1.4 ± 0.5 1.4 ± 0.5 1.4 ± 0.5 0.606
Religion 0.850
No 198(87.2%) 140(87.0%) 58(87.9%)
Yes 29(12.8%) 21(13.0%) 8(12.1%)
BMI 0.155
<25 182(80.2%) 125(77.6%) 57(86.4%)
≥ 25 45(19.8%) 36(22.4%) 9(13.6%)
Concern about arteriovenous fistula 0.032*
Always 67(29.5%) 43(26.7%) 24(36.4%)
Frequently 37(16.3%) 22(13.7%) 15(22.7%)
Not at all 123(54.2%) 96(59.6%) 27(40.9%)
Renal disease duration (months) 0.382
≤ 40 71(31.3%) 46(28.6%) 25(37.9%)
41–89 82(36.1%) 61(37.9%) 21(31.8%)
≥ 90 74(32.6%) 54(33.5%) 20(30.3%)
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Table 1 Demographic characteristics of HD patients with low and normal mood (Continued)
Activities of daily living 15.4 ± 3.9 18.1 ± 6.3 <0.001***
SF-36 (mean ± SD)a
Physical functioning 81.1 ± 18.3 67.7 ± 24.4 <0.001***
Role limitation due to
physical problems
53.1 ± 40.7 28.8 ± 38.0 <0.001***
Role limitation due to emotional problems 78.9 ± 32.6 44.9 ± 45.5 <0.001***
Social functioning 69.4 ± 22.2 47.3 ± 24.8 <0.001***
Mental health 85.7 ± 12.8 54.9 ± 22.9 <0.001***
Energy and vitality 69.1 ± 18.7 42.8 ± 21.0 <0.001***
Bodily pain 82.4 ± 25.7 63.6 ± 34.1 <0.001***
General perception of health 49.3 ± 20.2 29.1 ± 16.9 <0.001***
Social support (mean ± SD)a
Family support 25.3 ± 2.6 23.5 ± 3.6 <0.001***
Outside family support 44.5 ± 8.9 37.7 ± 11.1 <0.001***
Coping style (mean ± SD)a
Confrontation 18.8 ± 4.5 17.9 ± 4.5 0.149
Avoidance 18.1 ± 3.3 17.1 ± 3.1 0.041*
Acceptance-resignation 10.6 ± 1.9 11.9 ± 2.3 <0.001***
Self-efficacy (mean ± SD)a 29.7 ± 6.7 24.4 ± 7.6 <0.001***
Ego resiliency (mean ± SD)a 41.1 ± 7.9 36.4 ± 6.9 <0.001***
* p < 0.05; ** p < 0.01; *** p < 0.001
a Independent-samples t test
b Median and inter-quartile range
c Mann-Whitney U test
Table 2 The multivariate logistic regression analysis for
exploring factors of depressive symptoms
Variables OR OR 95%CI p value
Age 0.990 0.963 ~ 1.017 0.457
Gender
(male vs. female)
0.798 0.379 ~ 1.680 0.552
Activities of daily living 1.124 1.043 ~ 1.212 0.002**
Social support
Family support 0.867 0.768 ~ 0.979 0.021*
Outside family support 0.972 0.935 ~ 1.010 0.148
Coping style
Confrontation 0.980 0.903 ~ 1.062 0.619
Aviodance 0.966 0.861 ~ 1.084 0.558
Acceptance-resignation 1.228 1.030 ~ 1.466 0.022*
Self-efficacy 0.965 0.914 ~ 1.019 0.202
Ego resiliency 0.944 0.899 ~ 0.991 0.021*
HD duration (months)
(>60 vs. ≤24)
2.154 0.860 ~ 5.395 0.101
HD duration (months)
(25–60 vs. ≤24)
1.182 0.486 ~ 2.878 0.712
*p < 0.05; ** p < 0.01
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on HD, the findings showed that aerobic physical activity
was associated with fewer depression symptoms [34].
Finding some effective physical activity regimens which
were suitable for Chinese HD people to improve the
functional status may be a feasible scheme to reduce de-
pressive symptoms in patients under HD treatment.
In our study, we found that patients with a lower
mood received less social support than patients with bet-
ter mood, including both family support and outside
family support. And family support was negatively asso-
ciated with low mood. Our finding was in agreement
with previous study in patients on peritoneal dialysis
(PD) in southern China [35]. Social support refers to the
perception and actuality that one gets assistance from
other people [36]. HD as a long-term management strat-
egy, patients under HD treatment may lose personal
freedom and social connectedness [37]. The characteris-
tic of HD treatment changes the life style of family care-
givers too. It is important that not only for the patients,
but also for the family members to focus on preparation
for the change to the new way of life [38]. According to
our result, family support is associated with low mood,
the support received from family is more important to
the patients under HD treatment. For example, patients
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tion to and from the dialysis unit, and discussed with
them the difficulties associated with HD [39, 40]. As
family support is highly valued, the family members
should give more advice and help.
In assessing the coping style, patients with a lower mood
more like to select “acceptance-resignation” coping style
than patients with better mood. And “acceptance-resigna-
tion” coping style was associated with low mood inde-
pendently. This result was in agreement with previous
study in patients on peritoneal dialysis (PD) in southern
China [35]. Patients on HD must confront with constant
threat of diseases and death, which will impose them
many challenges and difficulties, and will often require
new and different ways to cope with. This result suggested
that patients with low mood were inclined to the usage of
“acceptance-resignation” coping style. Use of this type of
coping style indicates a lack of hope, shows that patients
under HD regard their disease as non-solving, so it is not
surprising that “acceptance-resignation” coping style are
associated with low mood in patients on HD.
In our study, we also found that patients with a better
mood have better ego resiliency than patients with lower
mood. And ego resiliency was independently associated
with low mood. Ego resiliency is an individual’s ability to
adapt to stress and adversity. Individuals with better
ego-resiliency are likely to adjust well to changing envir-
onment [41]. Thus, physicians should evaluate ego-
resiliency of HD patients, and help them developing
ego-resiliency may moderate the happening of the de-
pressive symptoms.
We could speculate on the situation of the whole
population according to results of this study, based on
the property of cluster sampling. However, several limi-
tations of our study should be considered. First, patients
recruited in our study were only from two affiliated hos-
pitals which may limit to public hospitals in city. Second,
since this study is a cross-sectional study, we couldn’t
get causality based on our findings, further longitudinal
studies with treatment interventions is necessary.
Conclusions
In conclusion, based on cross-sectional survey, our find-
ings revealed that in HD patients in northern China, the
prevalence of depressive symptoms was high. ADL, family
support, “acceptance-resignation” coping style and ego re-
siliency were independently associated with depressive
symptoms. Physicians should give more attention to pre-
vent and treat depressive symptoms among HD patients.
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